Pulmonary Nodular Lymphoid Hyperplasia: A Rare Case Mimicking Malignancy

Document Type : Case Report

Authors

1 Thoracic Surgeon, Trakya University Faculty of Medicine, Thoracic Surgery, Edirne, Turkey

2 Pathologist, Trakya University Faculty of Medicine, Pathology, Edirne, Turkey

Abstract

Pulmonary nodular lymphoid hyperplasia (PNLH) is a reactive lymphoid proliferation manifesting as multiple solitary nodules or localized infiltrates in the lungs. It is a type of benign lymphoproliferative disease that can affect the lungs. We present the case of a 41-year-old female patient with respiratory symptoms such as productive cough, left chest pain, and dyspnea. Imaging findings revealed two lesions with lobulated contour in the left upper lobe apicoposterior segment and left lower lobe superior segment. After examining the minimally invasive diagnostic methods, this rare PNLH case mimicking malignancy was both diagnosed and treated by surgery. Further studies including more patients and longer follow-ups are needed for this rare disease.

Keywords

References

1.Karube Y, Chida M, Honma K, Araki O, Kobayashi S, Miyıshi S. Nodular lymphoid hyperplasia: rare case of lymphoproliferative disease in the lung. Gen Thorac Cardiovasc Surg. 2009; 57:324-7.
2. Rogoziński P, Bruliński K, Malinowski E, Wandzel P, Kucharzewski M. Nodular lymphoid hyperplasia - a rare case of lymphoproliferative disorder of the lungs Pneumonol Alergol Pol. 2013; 81:68-72.
3. Sirajuddin A, Raparia K, Lewis VA, Franks TJ, Dhand S, Galvin JR, et al. Primary pulmonary lymphoid lesions: radiologic and pathologic findings. RadioGraphics. 2016; 36:53-70.
4. Poletti V, Ravaglia C, Tomassetti S, Gurioli C, Casoni G, Asioli S, et al. Lymphoproliferative lung disorders: clinicopathological aspects. Eur Respir Rev. 2013; 22:427-36.
5. Kradin RL, Mark EJ. Benign lymphoid disorders of the lung, with a theory regarding their development. Hum Pathol. 1983; 14:857–67.
6. Vardiman JW, Arber DA, Brunning RD, Larson RA, Matutes E, Baumann I, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008.
7. Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur Respir J. 2002; 20:750-62.
8. Judge EP, Abrahams J, Costigan D, McWeeney D, Healy D, Dodd JD, et al. Pulmonary nodular lymphoid hyperplasia presenting cavitating pulmonary nodules. Pathol Res Pract. 2015; 211:1006-9.
9. Abbondanzo SL, Rush W, Bijwaard KE, Koss MN. Nodular lymphoid hyperplasia of the lung: a clinicopathologic study of 14 cases. Am J Surg
Pathol. 2000; 24:587-97.
10. Hare SS, Souza CA, Bain G, Seely JM, Frcpc, Gomes MM, et al. The radiological spectrum of pulmonary lymphoproliferative disease. Br J Radiol. 2012; 85:848-64.
11. Bois MC, Sekiguchi H, Ryu JH, Yi ES. No definite clinical features of immunoglobulin G4-related disease in patients with pulmonary nodular lymphoid hyperplasia. Hum Pathol. 2017; 59:80-6.
12. Lee G, Lee HY, Lee KS, Lee KJ, Cha HS, Han J, et al. Imaging manifestations of autoimmune disease- associated lymphoproliferative disorders of the lung. Clin Rheumatol. 2013; 32:1459-65.
13. Yilmaz U, Unsal I, Halilçolar H, Anar C, Yildirim Y, Sanli A, et al. Nodular lymphoid hyperplasia of the lung: the role of positron emission tomography in diagnosis. Tuberk Toraks. 2009; 57:417-21.
14. Suga K, Yasuhiko K, Hiyama A, Hori K, Tanaka N, Ueda K. F-18 FDG PET/CT findings in a case of multifocal nodular lymphoid hyperplasia of the lung. Clin Nucl Med. 2009; 34:374-6.
Journal of Cardio-Thoracic Medicine
Volume 6, Issue 1
March 2018
Pages 265-269

Files

Share

How to cite

Statistics